The Medicines and Healthcare Products Regulatory Agency (MHRA) has ruled that warnings about the risk should now be added to drugs like Ozempic, Wegovy and Mounjaro.

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide (Wegovy and Ozempic) and tirzepatide (Mounjaro) may ...

Severe dysphagia significantly increases mortality risk after PEG, a new study finds. Patients with severe swallowing ...